11/14
04:10 pm
alrn
Form 8-K Aileron Therapeutics, For: Nov 14
High
Report
Form 8-K Aileron Therapeutics, For: Nov 14
11/14
04:05 pm
alrn
Form 10-Q Aileron Therapeutics, For: Sep 30
High
Report
Form 10-Q Aileron Therapeutics, For: Sep 30
11/5
05:18 pm
alrn
Form SCHEDULE 13G/A Aileron Therapeutics, Filed by: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Low
Report
Form SCHEDULE 13G/A Aileron Therapeutics, Filed by: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
8/22
04:09 pm
alrn
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Aivado Manuel
Medium
Report
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Aivado Manuel
8/22
04:07 pm
alrn
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Fairey William
Medium
Report
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Fairey William
8/22
04:07 pm
alrn
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: VON RICKENBACH JOSEF H
Medium
Report
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: VON RICKENBACH JOSEF H
8/22
04:06 pm
alrn
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Musso Alan A
Medium
Report
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Musso Alan A
8/22
04:06 pm
alrn
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Ambros Reinhard J.
Medium
Report
Form 4 Aileron Therapeutics, For: Aug 20 Filed by: Ambros Reinhard J.